Neoadjuvant nivolumab plus ipilimumab

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

June, 2025

Neoadjuvant nivolumab plus ipilimumab

Nov 1, 2024, 05:37 | Immune Oncology

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Immunotherapy has revolutionized the treatment of melanoma, particularly for advanced or metastatic cases. By harnessing…

Jun 30, 2024, 14:51 | Insight

Sergio Cifuentes: Phase 2 study on neoadjuvant nivolumab + ipilimumab in dMMR colon cancer

Sergio Cifuentes, Cancer Research Project Manager at CENEIT México, shared a post on X about…

Jun 7, 2024, 01:18 | Insight

Giuseppe Curigliano: Congratulations to Myriam Chalabi on her outstanding paper

Giuseppe Curigliano shared a post by NEJM on X: "Congratulations to Myriam Chalabi on her outstanding…

All: 3 Posts: 1 - 100

'

Garo Armen Shares a Personal Story Driving Agenus' Mission in Cancer Care

'

Dr. Oliver Bogler, PhD: Leaving the National Cancer Institute

'

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care

'

Sibylle Loibl: Final survival Results from the PENELOPE-B trial published in Annals of Oncology

'

Yvonne Awards 2025: Honoring Global Oncology Leaders at ASCO’s Most Inspiring Night

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023